Statements of Cash Flows - USD ($)	2 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (15,806)	$ (1,002,595)
Adjustments to reconcile net loss to net cash used in operating activities
Change in fair value of warrant liabilities		(18,560)
Interest income and dividend income earned in cash and investments income held in trust account		(2,930)
Change in operating assets and liabilities:
Increase in prepayment		(62,484)
Increase in accrued liabilities	2,967	15,549
Net cash used in operating activities	(12,839)	(1,071,020)
Cash flows from investing activities:
Proceeds deposited in Trust Account		(46,920,000)
Net cash used in investing activities		(46,920,000)
Cash flows from financing activities:
Proceeds from public offering		44,920,000
Proceeds from private placements		3,040,000
Proceed from issuance of ordinary shares	25,000
Advances from a related party	12,839	153,028
Payment of offering costs	(25,000)
Net cash provided by financing activities	12,839	48,113,028
NET CHANGE IN CASH		122,008
CASH, BEGINNING OF PERIOD
CASH, END OF PERIOD		122,008
Non-cash investing and financing activities
Initial classification of ordinary shares subject to possible redemption	20,000	44,792,363
Allocation of offering costs to ordinary shares subject to redemption		2,887,160
Accretion of carrying value to redemption value		(5,014,797)
Accrued underwriting compensation		1,840,000
Initial recognition of warrant liabilities		1,258,560
Deferred offering costs paid by a related party	$ 20,000